Understanding primary care physician perspectives on recommending HPV vaccination and addressing vaccine hesitancy

References

• Chao C, Velicer C, Slezak JM, Jacobsen SJ. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol. 2010;171(3):357–67. doi:10.1093/aje/kwp365.
   PubMed Web of Science ®Google Scholar
• Lau M, Lin H, Flores G. Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children’s Health. Vaccine. 2012;30(20):3112–18. doi:10.1016/j.vaccine.2012.02.034.
   PubMed Web of Science ®Google Scholar
• Cook RL, Zhang J, Mullins J, Kauf T, Brumback B, Steingraber H, Mallison C. Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid. J Adolesc Health. 2010;47(6):596–99. doi:10.1016/j.jadohealth.2010.09.015.
   PubMed Web of Science ®Google Scholar
• Burger EA, Lee K, Saraiya M, Thompson TD, Chesson HW, Markowitz LE, Kim JJ. Racial and ethnic disparities in human papillomavirus-associated cancer burden with first-generation and second-generation human papillomavirus vaccines. Cancer. 2016;122(13):2057–66. doi:10.1002/cncr.30007.
   PubMed Web of Science ®Google Scholar
• American Cancer Society. Cancer facts & figures 2018. [Accessed 2018, Jan 24]. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf.
   Google Scholar
• US Cancer Statistics Working Group. United States Cancer Statistics: 1999–2007 Incidence and Mortality Web-based Report. 2010. [Accessed 2011, Nov 17. www.cdc.gov/uscs.
   Google Scholar
• Benard VB, Johnson CJ, Thompson TD, Roland KB, Lai SM, Cokkinides V, Tangka F, Hawkins NA, Lawson H, Weir HK. Examining the association between socioeconomic status and potential human papillomavirus-associated cancers. Cancer. 2008;113(10 Suppl):2910–18. doi:10.1002/cncr.23742.
   PubMed Web of Science ®Google Scholar
• Freeman H, Wingrove B. Excess cervical cancer mortality: a marker for low access to health care in poor communities. Rockville (MD): National Cancer Insitute; 2005.
   Google Scholar
• Dempsey AF, Pyrznawoski J, Lockhart S, Barnard J, Campagna EJ, Garrett K, Fisher A, Dickinson LM, O’Leary ST. Effect of a health care professional communication training intervention on adolescent human papillomavirus vaccination: a cluster randomized clinical trial. JAMA Pediatr. 2018;172(5):e180016. doi:10.1001/jamapediatrics.2018.0016.
   PubMed Web of Science ®Google Scholar
• Niccolai LM, Hansen CE. Practice- and community-based interventions to increase human papillomavirus vaccine coverage: a systematic review. JAMA Pediatr. 2015;169(7):686–92. doi:10.1001/jamapediatrics.2015.0310.
   PubMed Web of Science ®Google Scholar
• Perkins RB, Brogly SB, Adams WG, Freund KM. Correlates of human papillomavirus vaccination rates in low-income, minority adolescents: a multicenter study. J Womens Health (Larchmt). 2012;21(8):813–20. doi:10.1089/jwh.2011.3364.
   PubMed Web of Science ®Google Scholar
• Perkins RB, Zisblatt L, Legler A, Trucks E, Hanchate A, Gorin SS. Effectiveness of a provider-focused intervention to improve HPV vaccination rates in boys and girls. Vaccine. 2015;33:1223–29.
   PubMed Web of Science ®Google Scholar
• Smulian EA, Mitchell KR, Stokley S. Interventions to increase HPV vaccination coverage: A systematic review. Hum Vaccin Immunother. 2016;12(6):1566–88. doi:10.1080/21645515.2015.1125055.
   PubMed Web of Science ®Google Scholar
• Fu LY, Bonhomme LA, Cooper SC, Joseph JG, Zimet GD. Educational interventions to increase HPV vaccination acceptance: a systematic review. Vaccine. 2014;32(17):1901–20. doi:10.1016/j.vaccine.2014.01.091.
   PubMed Web of Science ®Google Scholar
• Gilkey MB, Malo TL, Shah PD, Hall ME, Brewer NT. Quality of physician communication about human papillomavirus vaccine: findings from a national survey. Cancer Epidemiol Biomarkers Prev. 2015;24(11):1673–79. doi:10.1158/1055-9965.EPI-15-0326.
   PubMed Web of Science ®Google Scholar
• Gilkey MB, McRee AL. Provider communication about HPV vaccination: A systematic review. Hum Vaccin Immunother. 2016;12(6):1454–68. doi:10.1080/21645515.2015.1129090.
   PubMed Web of Science ®Google Scholar
• McRee AL, Gilkey MB, Dempsey AF. HPV vaccine hesitancy: findings from a statewide survey of health care providers. J Pediatr Health Care. 2014;28(6):541–49. doi:10.1016/j.pedhc.2014.05.003.
   PubMed Web of Science ®Google Scholar
• Shay LA, Baldwin AS, Betts AC, Marks EG, Higashi RT, Street RL, Persaud D, Tiro JA. Parent-Provider Communication of HPV Vaccine Hesitancy. Pediatrics. 2018;141(6):e20172312. doi:10.1542/peds.2017-2312.
   PubMed Web of Science ®Google Scholar
• Attwell K, Dube E, Gagneur A, Omer SB, Suggs LS, Thomson A. Vaccine acceptance: science, policy, and practice in a ‘post-fact’ world. Vaccine. 2019;37(5):677–82. doi:10.1016/j.vaccine.2018.12.014.
   PubMed Web of Science ®Google Scholar
• Dubé E, Gagnon D, MacDonald NE. Strategies intended to address vaccine hesitancy: review of published reviews. Vaccine. 2015;33(34):4191–203. doi:10.1016/j.vaccine.2015.04.041.
   PubMed Web of Science ®Google Scholar
• Hennink MM, Kaiser BN, Marconi VC. Code Saturation Versus Meaning Saturation: how Many Interviews Are Enough? Qual Health Res. 2017;27(4):591–608. doi:10.1177/1049732316665344.
   PubMed Web of Science ®Google Scholar
• Spradley J. The Ethnographic Interview. Forth Worth (Texas): Harcourt Brace Jovanovich College Publishers; 1979.
   Google Scholar
• Crabtree BF, Miller W. Doing qualitative research. Thousand Oaks (USA): SAGE Publications; 1999.
   Google Scholar
• Crabtree BF, Miller W. Doing qualitative research. In: Using codes and code manuals: A template for organizing style of interpretation.. Newbury Park (CA): SAGE Publications; 1999; 163–78.
   Google Scholar
• Cunningham-Erves J, Koyama T, Huang Y, Jones J, Wilkins CH, Harnack L, McAfee C, Hull PC. Providers’ perceptions of parental human papillomavirus vaccine hesitancy: cross-sectional study. JMIR Cancer. 2019;5(2):e13832. doi:10.2196/13832.
   PubMed Web of Science ®Google Scholar
• National HPV Vaccine Roundtable. Clinician & Health Systems Action Guides. 2019. [Accessed 2020 Oct, 23. https://hpvroundtable.org/action-guides/.
   Google Scholar
• Baezconde-Garbanati L, Lienemann BA, Robles M, Johnson E, Sanchez K, Singhal R, Steinberg J, Jaque JM, Pentz MA, Gruber S. Implementation of HPV vaccination guidelines in a diverse population in Los Angeles: results from an environmental scan of local HPV resources and needs. Vaccine. 2017;35(37):4930–35. doi:10.1016/j.vaccine.2017.07.080.
   PubMed Web of Science ®Google Scholar
• Carhart MY, Schminkey DL, Mitchell EM, Keim-Malpass J. Barriers and Facilitators to Improving Virginia’s HPV vaccination rate: a stakeholder analysis with implications for pediatric nurses. J Pediatr Nurs. 2018;42:1–8.
   PubMed Web of Science ®Google Scholar
• Dilley SE, Peral S, Straughn JM, Scarinci IC. The challenge of HPV vaccination uptake and opportunities for solutions: lessons learned from Alabama. Prev Med. 2018;113:124–31. doi:10.1016/j.ypmed.2018.05.021.
   PubMed Web of Science ®Google Scholar
• National Center for Immunization and Respiratory Diseases. 2008 through 2019 Adolescent Human Papillomavirus (HPV) Vaccination Coverage Trend Report. 2020. Accessed Oct 23, 2020. https://www.cdc.gov/vaccines/imz-managers/coverage/teenvaxview/data-reports/hpv/trend/index.html.
   Google Scholar
• Gaglio B, Shoup JA, Glasgow RE. The RE-AIM framework: a systematic review of use over time. Am J Public Health. 2013;103(6):e38–46. doi:10.2105/AJPH.2013.301299.
   PubMed Web of Science ®Google Scholar
• Walling EB, Benzoni N, Dornfeld J, Bhandari R, Sisk BA, Garbutt J, Colditz G. Interventions to Improve HPV Vaccine Uptake: A Systematic Review. Pediatrics. 2016;138:1. doi:10.1542/peds.2015-3863.
   Web of Science ®Google Scholar
• Garbutt JM, Dodd S, Walling E, Lee AA, Kulka K, Lobb R. Barriers and facilitators to HPV vaccination in primary care practices: a mixed methods study using the Consolidated Framework for Implementation Research. BMC Fam Pract. 2018;19(1):53. doi:10.1186/s12875-018-0750-5.
   PubMedGoogle Scholar
• Kasting ML, Christy SM, Sutton SK, Lake P, Malo TL, Roetzheim RG, Schechtman T, Zimet GD, Walkosz BJ, Salmon D, et al. Florida physicians’ reported use of AFIX-based strategies for human papillomavirus vaccination. Prev Med. 2018;116:143–49. doi:10.1016/j.ypmed.2018.09.004.
   PubMed Web of Science ®Google Scholar
• Reno JE, O’Leary ST, Pyrzanowski J, Lockhart S, Thomas J, Dempsey AF. Evaluation of the implementation of a multicomponent intervention to improve health care provider communication about human papillomavirus vaccination. Acad Pediatr. 2018;18(8):882–88. doi:10.1016/j.acap.2018.08.004.
   PubMed Web of Science ®Google Scholar
• Selove R, Foster M, Mack R, Sanderson M, Hull PC. Using an implementation research framework to identify potential facilitators and barriers of an intervention to increase HPV vaccine uptake. J Public Health Man. 2017;23:E1–E9.
   PubMed Web of Science ®Google Scholar
• Rodriguez SA, Mullen PD, Lopez DM, Savas LS, Fernández ME. Factors associated with adolescent HPV vaccination in the U.S.: a systematic review of reviews and multilevel framework to inform intervention development. Prev Med. 2020;131:105968. doi:10.1016/j.ypmed.2019.105968.
   PubMed Web of Science ®Google Scholar
• Bednarczyk RA, Chamberlain A, Mathewson K, Salmon DA, Omer SB. Practice-, Provider-, and Patient-level interventions to improve preventive care: development of the P3 Model. Prev Med Rep. 2018;11:131–38. doi:10.1016/j.pmedr.2018.06.009.
   PubMedGoogle Scholar